252 related articles for article (PubMed ID: 33259565)
1. Violence and hepatitis C transmission in prison-A modified social ecological model.
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
[TBL] [Abstract][Full Text] [Related]
2. Acquiring hepatitis C in prison: the social organisation of injecting risk.
Treloar C; McCredie L; Lloyd AR;
Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
[TBL] [Abstract][Full Text] [Related]
3. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
4. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
[TBL] [Abstract][Full Text] [Related]
5. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of hepatitis C incidence in Australian prisoners.
Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
[TBL] [Abstract][Full Text] [Related]
10. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
Hellard ME; Hocking JS; Crofts N
Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson W; Kaldor J; Lloyd A; Haber P
Eur J Epidemiol; 2010 Feb; 25(2):143-8. PubMed ID: 20084429
[TBL] [Abstract][Full Text] [Related]
13. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J;
Int J Drug Policy; 2018 Apr; 54():18-25. PubMed ID: 29367011
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of hepatitis C virus among prisoners in Scotland.
Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
[TBL] [Abstract][Full Text] [Related]
18. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
[TBL] [Abstract][Full Text] [Related]
19. EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON.
Nelwan EJ; Indrati AK; Isa A; Triani N; Alam NN; Herlan MS; Husen W; Pohan HT; Alisjahbana B; Meheus A; Van Crevel R; van der Ven AJ
Southeast Asian J Trop Med Public Health; 2015 Sep; 46(5):880-91. PubMed ID: 26863859
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
Peña-Orellana M; Hernández-Viver A; Caraballo-Correa G; Albizu-García CE
J Health Care Poor Underserved; 2011 Aug; 22(3):962-82. PubMed ID: 21841290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]